Please login to the form below

Not currently logged in
Email:
Password:

venture capital

This page shows the latest venture capital news and features for those working in and with pharma, biotech and healthcare.

UK biotech funding falls 40% between 2018 and 2019

UK biotech funding falls 40% between 2018 and 2019

Out of that amount, £679m was raised in venture capital, £64m was raised in Initial Public Offerings (IPOs) and £596m in all other public financings. ... According to the report, global venture capital deals totalled £14.5bn in 2019, down 12%, with

Latest news

More from news
Approximately 2 fully matching, plus 106 partially matching documents found.

Latest Intelligence

  • Can protein degraders unlock ‘undruggable’ drug targets? Can protein degraders unlock ‘undruggable’ drug targets?

    It raised $30m in its series A in 2017, and followed that up with a second-round fundraising last November that raised $67m and added Pfizer and Sanofi’s venture capital

  • BRIC markets BRIC markets

    The country is attracting increasing amounts of venture capital funding and we are going see some novel medicines developed in those labs being sold in international markets,” he concluded.

  • Driving the innovation engine Driving the innovation engine

    Rapid changes in technology and the increasing availability of venture capital and angel investors now mean that if an employee has a good idea, he or she can rapidly capitalise on ... The boundary is that it’s limited to the stakeholders – including,

  • Building European biotech firms to rival those of the US Building European biotech firms to rival those of the US

    Richard Mason (pictured above) is a veteran of the UK biotech industry, including a spell as CEO of company XO1 set up by venture capital investors Index Ventures (now Medicxi) in ... Europe will produce its own world class biotechs. Many people in life

  • European biotech: a new generation of leaders emerges European biotech: a new generation of leaders emerges

    biotechs’. The growing role of specialist venture capital. One of the key ingredients in these and other recent European biotech success stories is long-term backing from investors. ... One key venture capital fund is London-based Medicxi, which raised

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest from PMHub

  • Random42 Attending Jefferies 2018 London Healthcare Conference

    This global gathering of leading healthcare executives and institutional, private equity and venture capital investors will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare.

  • Random42 appoints Bill Collis as Chairman

    He has vast experience in venture capital and private equity funding, intellectual property licensing, mergers and acquisitions and accessing international markets.

  • Managing value: Why early asset development and commercialization is important

    Investors understand that it’s a gamble, but like every gambler they want the best odds. The figures really are staggering: there are companies with assets in development that have capital ... But while venture capital investors are pumping many

  • Big Bear Communications

    We are a Strategic Marketing Consultancy to the pharmaceuticals / biotech sector and our clients include companies from the sector as well as those from the Venture Capital / Private Equity sector.

  • BigBear Communications Ltd

    We are a Strategic Marketing Consultancy to the pharmaceuticals / biotech sector and our clients include companies from the sector as well as those from the Venture Capital / Private Equity sector.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics